SlideShare a Scribd company logo
Managing Oncology
Cost and Quality
John Hennessy, WellRithms
Site of service
• Physician office
• Hospital outpatient department
• Academic medical center
• NCI-designated cancer center
• Dedicated integrated specialty cancer facility
Demographics
• Hospital acquiring physician owned oncology
practices
• Decrease in freestanding practices to about half
what it was ten years ago; 2015 ASCO Oncology
Census reported 45% of those surveyed were in a
hospital-owned practice, 60% in the Midwest
• Often the same facility is suddenly a hospital
outpatient department
Cost Implications
• Avalere (2012): chemotherapy average cost $19,640 in
physician office, $26,300 hospital outpatient
• Milliman/Genentech (2013): hospital costs 28-52%
higher than physician office (adj/met breast/colon/
NSCLC)
• Moran (2013): chemotherapy cost/day 25-40% higher;
chemotherapy cost/episode 25-47% higher
• GAO (2015) recommends payment parity between
physician office and hospital outpatient setting
Drug Delivery models
• Physician office buy-and-bill
• HOPD buy-and-bill (340b)
• Specialty pharmacy
• White bagging
• Brown bagging
Out-of-Network
• Why does your network look like it does?
• Network adequacy: health plan network breadth
traded off against limited discounts
• In network may not mean affordable; selective
discounting and layered contracts (fully-funded vs.
ASO)
• Provider politics: Emory eliminates employee
coverage at CTCA-Georgia; UPMC vs. Highmark/
Allegheny
Why Out-of-Network?
• Patients choose their oncologist based on:
• PCP recommends one oncologist
• PCP suggests a choice of oncologists
• Patient asks friends for recommendations
• Patient searches internet
• Patient seeks advice/info from advocates/advocacy
group
Why Out-of-Network?
• Consumer Direct Advertising
• “We’ll work with your insurance…”
• Speak with a board-certified oncologist at NO
COST to get your questions answered and
determine if you are a candidate…”
• Second opinion advertising
Other factors
• Financial toxicity
• Logistical toxicity
• SPD/benefit design
• Clinical trials

More Related Content

What's hot

A Look at National Cancer Institute Designations
A Look at National Cancer Institute DesignationsA Look at National Cancer Institute Designations
A Look at National Cancer Institute Designations
Sherif El Refai
 
Patient-Reported Outcomes in Cancer Care - Zeena Nackerdien
Patient-Reported Outcomes in Cancer Care - Zeena NackerdienPatient-Reported Outcomes in Cancer Care - Zeena Nackerdien
Patient-Reported Outcomes in Cancer Care - Zeena Nackerdien
Zeena Nackerdien
 
Do we need a new system to price oncology pharmaceuticals?
Do we need a new system to price oncology pharmaceuticals?Do we need a new system to price oncology pharmaceuticals?
Do we need a new system to price oncology pharmaceuticals?
Cancer Institute NSW
 
CURE OM Patient Registry Update - Jacqueline Kraska
CURE OM Patient Registry Update - Jacqueline KraskaCURE OM Patient Registry Update - Jacqueline Kraska
CURE OM Patient Registry Update - Jacqueline Kraska
Melanoma Research Foundation
 
Modelling the Impact of Reform to the Cancer Drugs Fund
Modelling the Impact of Reform to the Cancer Drugs FundModelling the Impact of Reform to the Cancer Drugs Fund
Modelling the Impact of Reform to the Cancer Drugs Fund
Office of Health Economics
 
EWMA 2014 - EP466 LINK BETWEEN HOSPITAL-BASED DEPARTMENT OF WOUND HEALING AND...
EWMA 2014 - EP466 LINK BETWEEN HOSPITAL-BASED DEPARTMENT OF WOUND HEALING AND...EWMA 2014 - EP466 LINK BETWEEN HOSPITAL-BASED DEPARTMENT OF WOUND HEALING AND...
EWMA 2014 - EP466 LINK BETWEEN HOSPITAL-BASED DEPARTMENT OF WOUND HEALING AND...
EWMA
 
0307 Mary Wang - Biobanks and registries
0307 Mary Wang - Biobanks and registries0307 Mary Wang - Biobanks and registries
0307 Mary Wang - Biobanks and registries
Workgroup of European Cancer Patient Advocacy Networks
 
Academyhealth 2013 How are Rural Hospitals Using Hospitalists?
Academyhealth 2013 How are Rural Hospitals Using Hospitalists?Academyhealth 2013 How are Rural Hospitals Using Hospitalists?
Academyhealth 2013 How are Rural Hospitals Using Hospitalists?
Peiyin Hung
 
0306 1 Sergio Diaz - Patient Reported Outcomes
0306 1 Sergio Diaz - Patient Reported Outcomes0306 1 Sergio Diaz - Patient Reported Outcomes
0306 1 Sergio Diaz - Patient Reported Outcomes
Workgroup of European Cancer Patient Advocacy Networks
 
CURE Poster Presentation_V8
CURE Poster Presentation_V8CURE Poster Presentation_V8
CURE Poster Presentation_V8Hawa Barry
 
Asra defining value may 2015
Asra defining value may 2015Asra defining value may 2015
Asra defining value may 2015
Colin McCartney
 
0306 2 Madelaine Pe - Analysing and Comparing PRO
0306 2 Madelaine Pe - Analysing and Comparing PRO0306 2 Madelaine Pe - Analysing and Comparing PRO
0306 2 Madelaine Pe - Analysing and Comparing PRO
Workgroup of European Cancer Patient Advocacy Networks
 
Az Cert Educational Projects Pres 08 09
Az Cert Educational Projects Pres 08 09Az Cert Educational Projects Pres 08 09
Az Cert Educational Projects Pres 08 09
mlbrown
 
The Value of Targeted Sequencing in Advanced Cancer: DCE to Elicit the Public...
The Value of Targeted Sequencing in Advanced Cancer: DCE to Elicit the Public...The Value of Targeted Sequencing in Advanced Cancer: DCE to Elicit the Public...
The Value of Targeted Sequencing in Advanced Cancer: DCE to Elicit the Public...
Office of Health Economics
 
Whitepaper #5 the_data_mineinc_differentiate_or_dissipate
Whitepaper #5 the_data_mineinc_differentiate_or_dissipateWhitepaper #5 the_data_mineinc_differentiate_or_dissipate
Whitepaper #5 the_data_mineinc_differentiate_or_dissipateBarbara Haimowitz
 
Is balancing value demonstration for payers and patient interests a feasible ...
Is balancing value demonstration for payers and patient interests a feasible ...Is balancing value demonstration for payers and patient interests a feasible ...
Is balancing value demonstration for payers and patient interests a feasible ...
Office of Health Economics
 
PC15013_ConferencePreview
PC15013_ConferencePreviewPC15013_ConferencePreview
PC15013_ConferencePreviewDaria Binder
 
Making value-based pricing a reality – the case for multi-indication pricing
Making value-based pricing a reality – the case for multi-indication pricing Making value-based pricing a reality – the case for multi-indication pricing
Making value-based pricing a reality – the case for multi-indication pricing
Office of Health Economics
 

What's hot (20)

A Look at National Cancer Institute Designations
A Look at National Cancer Institute DesignationsA Look at National Cancer Institute Designations
A Look at National Cancer Institute Designations
 
Patient-Reported Outcomes in Cancer Care - Zeena Nackerdien
Patient-Reported Outcomes in Cancer Care - Zeena NackerdienPatient-Reported Outcomes in Cancer Care - Zeena Nackerdien
Patient-Reported Outcomes in Cancer Care - Zeena Nackerdien
 
Do we need a new system to price oncology pharmaceuticals?
Do we need a new system to price oncology pharmaceuticals?Do we need a new system to price oncology pharmaceuticals?
Do we need a new system to price oncology pharmaceuticals?
 
CURE OM Patient Registry Update - Jacqueline Kraska
CURE OM Patient Registry Update - Jacqueline KraskaCURE OM Patient Registry Update - Jacqueline Kraska
CURE OM Patient Registry Update - Jacqueline Kraska
 
Modelling the Impact of Reform to the Cancer Drugs Fund
Modelling the Impact of Reform to the Cancer Drugs FundModelling the Impact of Reform to the Cancer Drugs Fund
Modelling the Impact of Reform to the Cancer Drugs Fund
 
EWMA 2014 - EP466 LINK BETWEEN HOSPITAL-BASED DEPARTMENT OF WOUND HEALING AND...
EWMA 2014 - EP466 LINK BETWEEN HOSPITAL-BASED DEPARTMENT OF WOUND HEALING AND...EWMA 2014 - EP466 LINK BETWEEN HOSPITAL-BASED DEPARTMENT OF WOUND HEALING AND...
EWMA 2014 - EP466 LINK BETWEEN HOSPITAL-BASED DEPARTMENT OF WOUND HEALING AND...
 
0307 Mary Wang - Biobanks and registries
0307 Mary Wang - Biobanks and registries0307 Mary Wang - Biobanks and registries
0307 Mary Wang - Biobanks and registries
 
Academyhealth 2013 How are Rural Hospitals Using Hospitalists?
Academyhealth 2013 How are Rural Hospitals Using Hospitalists?Academyhealth 2013 How are Rural Hospitals Using Hospitalists?
Academyhealth 2013 How are Rural Hospitals Using Hospitalists?
 
0306 1 Sergio Diaz - Patient Reported Outcomes
0306 1 Sergio Diaz - Patient Reported Outcomes0306 1 Sergio Diaz - Patient Reported Outcomes
0306 1 Sergio Diaz - Patient Reported Outcomes
 
CURE Poster Presentation_V8
CURE Poster Presentation_V8CURE Poster Presentation_V8
CURE Poster Presentation_V8
 
Asra defining value may 2015
Asra defining value may 2015Asra defining value may 2015
Asra defining value may 2015
 
0306 2 Madelaine Pe - Analysing and Comparing PRO
0306 2 Madelaine Pe - Analysing and Comparing PRO0306 2 Madelaine Pe - Analysing and Comparing PRO
0306 2 Madelaine Pe - Analysing and Comparing PRO
 
Treatment m.feinberg
Treatment m.feinbergTreatment m.feinberg
Treatment m.feinberg
 
Az Cert Educational Projects Pres 08 09
Az Cert Educational Projects Pres 08 09Az Cert Educational Projects Pres 08 09
Az Cert Educational Projects Pres 08 09
 
The Value of Targeted Sequencing in Advanced Cancer: DCE to Elicit the Public...
The Value of Targeted Sequencing in Advanced Cancer: DCE to Elicit the Public...The Value of Targeted Sequencing in Advanced Cancer: DCE to Elicit the Public...
The Value of Targeted Sequencing in Advanced Cancer: DCE to Elicit the Public...
 
Whitepaper #5 the_data_mineinc_differentiate_or_dissipate
Whitepaper #5 the_data_mineinc_differentiate_or_dissipateWhitepaper #5 the_data_mineinc_differentiate_or_dissipate
Whitepaper #5 the_data_mineinc_differentiate_or_dissipate
 
RML Rendezvous - Health Information Literacy
RML Rendezvous - Health Information LiteracyRML Rendezvous - Health Information Literacy
RML Rendezvous - Health Information Literacy
 
Is balancing value demonstration for payers and patient interests a feasible ...
Is balancing value demonstration for payers and patient interests a feasible ...Is balancing value demonstration for payers and patient interests a feasible ...
Is balancing value demonstration for payers and patient interests a feasible ...
 
PC15013_ConferencePreview
PC15013_ConferencePreviewPC15013_ConferencePreview
PC15013_ConferencePreview
 
Making value-based pricing a reality – the case for multi-indication pricing
Making value-based pricing a reality – the case for multi-indication pricing Making value-based pricing a reality – the case for multi-indication pricing
Making value-based pricing a reality – the case for multi-indication pricing
 

Viewers also liked

Accountability In The Medicines Supply Chain
Accountability In The Medicines Supply ChainAccountability In The Medicines Supply Chain
Accountability In The Medicines Supply Chain
MeTApresents
 
Imp management at site (UA)
Imp management at site (UA)Imp management at site (UA)
Imp management at site (UA)
Pshot
 
Sepember 2011 FDA and Regulatory Inspections Argentina & Brazil
Sepember 2011 FDA and Regulatory Inspections  Argentina & BrazilSepember 2011 FDA and Regulatory Inspections  Argentina & Brazil
Sepember 2011 FDA and Regulatory Inspections Argentina & Brazil
anne_blanchard2009
 
Drug accountability
Drug accountabilityDrug accountability
Drug accountability
Upendra Agarwal
 
Pharmacy in clinical trials
Pharmacy in clinical trialsPharmacy in clinical trials
Pharmacy in clinical trialsChris Willmott
 
AS08_ProjectCharter_Cross
AS08_ProjectCharter_CrossAS08_ProjectCharter_Cross
AS08_ProjectCharter_CrossCorey Cross
 
Generalidades acerca de las TICs y la formación docente
Generalidades acerca de las TICs y la formación docenteGeneralidades acerca de las TICs y la formación docente
Generalidades acerca de las TICs y la formación docente
Jose Acevedo
 
So You Wanna Be a 501(c)(3)
So You Wanna Be a 501(c)(3)So You Wanna Be a 501(c)(3)
So You Wanna Be a 501(c)(3)Jeff Fromknecht
 
The Complete Study Lounge Sessions Non CA Specific
The Complete Study Lounge Sessions Non CA SpecificThe Complete Study Lounge Sessions Non CA Specific
The Complete Study Lounge Sessions Non CA SpecificDaniel J. Mastrantonio
 
Imagen nacional
Imagen nacionalImagen nacional
Imagen nacionalFrancy Ang
 
Jornal do mes de agosto 2012
Jornal do mes de agosto 2012Jornal do mes de agosto 2012
Jornal do mes de agosto 2012Gasparino Mikuska
 
AUTOCAD
AUTOCADAUTOCAD
Tutorial windows 7
Tutorial windows 7Tutorial windows 7
Tutorial windows 7
Leider Gutierrez
 
`Forever young' son cuts successor nikesh loose
`Forever young' son cuts successor nikesh loose`Forever young' son cuts successor nikesh loose
`Forever young' son cuts successor nikesh loose
Saxbee Consultants
 
Sportredskap
SportredskapSportredskap
Sportredskap
jekaterina53714
 
generalidades de miología
generalidades de miologíageneralidades de miología
generalidades de miología
IPN
 

Viewers also liked (20)

NYC 111315v2
NYC 111315v2NYC 111315v2
NYC 111315v2
 
Accountability In The Medicines Supply Chain
Accountability In The Medicines Supply ChainAccountability In The Medicines Supply Chain
Accountability In The Medicines Supply Chain
 
Imp management at site (UA)
Imp management at site (UA)Imp management at site (UA)
Imp management at site (UA)
 
Sepember 2011 FDA and Regulatory Inspections Argentina & Brazil
Sepember 2011 FDA and Regulatory Inspections  Argentina & BrazilSepember 2011 FDA and Regulatory Inspections  Argentina & Brazil
Sepember 2011 FDA and Regulatory Inspections Argentina & Brazil
 
Drug accountability
Drug accountabilityDrug accountability
Drug accountability
 
Pharmacy in clinical trials
Pharmacy in clinical trialsPharmacy in clinical trials
Pharmacy in clinical trials
 
AS08_ProjectCharter_Cross
AS08_ProjectCharter_CrossAS08_ProjectCharter_Cross
AS08_ProjectCharter_Cross
 
Generalidades acerca de las TICs y la formación docente
Generalidades acerca de las TICs y la formación docenteGeneralidades acerca de las TICs y la formación docente
Generalidades acerca de las TICs y la formación docente
 
So You Wanna Be a 501(c)(3)
So You Wanna Be a 501(c)(3)So You Wanna Be a 501(c)(3)
So You Wanna Be a 501(c)(3)
 
Murat_TOPÇU_Europass-CV-ESP-EN_27.04.2016
Murat_TOPÇU_Europass-CV-ESP-EN_27.04.2016Murat_TOPÇU_Europass-CV-ESP-EN_27.04.2016
Murat_TOPÇU_Europass-CV-ESP-EN_27.04.2016
 
The Complete Study Lounge Sessions Non CA Specific
The Complete Study Lounge Sessions Non CA SpecificThe Complete Study Lounge Sessions Non CA Specific
The Complete Study Lounge Sessions Non CA Specific
 
Bullying madi
Bullying madiBullying madi
Bullying madi
 
Dasar dasar ilmu sosial
Dasar dasar ilmu sosialDasar dasar ilmu sosial
Dasar dasar ilmu sosial
 
Imagen nacional
Imagen nacionalImagen nacional
Imagen nacional
 
Jornal do mes de agosto 2012
Jornal do mes de agosto 2012Jornal do mes de agosto 2012
Jornal do mes de agosto 2012
 
AUTOCAD
AUTOCADAUTOCAD
AUTOCAD
 
Tutorial windows 7
Tutorial windows 7Tutorial windows 7
Tutorial windows 7
 
`Forever young' son cuts successor nikesh loose
`Forever young' son cuts successor nikesh loose`Forever young' son cuts successor nikesh loose
`Forever young' son cuts successor nikesh loose
 
Sportredskap
SportredskapSportredskap
Sportredskap
 
generalidades de miología
generalidades de miologíageneralidades de miología
generalidades de miología
 

Similar to TH Jan 2016 v3

Current Issues Affecting Cancer Care in Puerto Rico
Current Issues Affecting Cancer Care in Puerto RicoCurrent Issues Affecting Cancer Care in Puerto Rico
Current Issues Affecting Cancer Care in Puerto Rico
flasco_org
 
Edifecs: Demonstrating who you are in CJR
Edifecs: Demonstrating who you are in CJREdifecs: Demonstrating who you are in CJR
Edifecs: Demonstrating who you are in CJR
Edifecs Inc
 
Pharmacy's Emerging Role in Accountable Care Organizations (ACO)
Pharmacy's Emerging Role in Accountable Care Organizations (ACO)Pharmacy's Emerging Role in Accountable Care Organizations (ACO)
Pharmacy's Emerging Role in Accountable Care Organizations (ACO)
Parata Systems
 
Debunking the myths about the hospitalists
Debunking the myths about the hospitalistsDebunking the myths about the hospitalists
Debunking the myths about the hospitalists
Guilherme Barcellos
 
powerpoint-presentation-Multi-verse tecto.pdf
powerpoint-presentation-Multi-verse tecto.pdfpowerpoint-presentation-Multi-verse tecto.pdf
powerpoint-presentation-Multi-verse tecto.pdf
ssuser9828ab
 
Transitioning to Value Based Care: Tennessee Oncology, A Case Study
Transitioning to Value Based Care: Tennessee Oncology, A Case StudyTransitioning to Value Based Care: Tennessee Oncology, A Case Study
Transitioning to Value Based Care: Tennessee Oncology, A Case Study
Wes Chapman
 
Physician age and outcomes in elderly patients in hospial in the US: observat...
Physician age and outcomes in elderly patients in hospial in the US: observat...Physician age and outcomes in elderly patients in hospial in the US: observat...
Physician age and outcomes in elderly patients in hospial in the US: observat...
Akshay Mehta
 
Duke Industry Statistics Symposium - Real world evidence , EHRs and Cancer S...
Duke Industry Statistics Symposium -  Real world evidence , EHRs and Cancer S...Duke Industry Statistics Symposium -  Real world evidence , EHRs and Cancer S...
Duke Industry Statistics Symposium - Real world evidence , EHRs and Cancer S...
Warren Kibbe
 
Care by design magill retrospective mixed methods analysis sep 21 2011
Care by design magill retrospective mixed methods analysis sep 21 2011Care by design magill retrospective mixed methods analysis sep 21 2011
Care by design magill retrospective mixed methods analysis sep 21 2011
Paul Grundy
 
Brian Griffin
Brian GriffinBrian Griffin
Brian Griffin
Investnet
 
How Hospitalists Can Lead on Quality
How Hospitalists Can Lead on QualityHow Hospitalists Can Lead on Quality
How Hospitalists Can Lead on Quality
Modern Healthcare
 
Impact of Multidisciplinary Discussion on Treatment Outcome For Gynecologic C...
Impact of Multidisciplinary Discussion on Treatment Outcome For Gynecologic C...Impact of Multidisciplinary Discussion on Treatment Outcome For Gynecologic C...
Impact of Multidisciplinary Discussion on Treatment Outcome For Gynecologic C...
Emad Shash
 
How to Engage Physicians in Best Practices to Respond to Healthcare Transform...
How to Engage Physicians in Best Practices to Respond to Healthcare Transform...How to Engage Physicians in Best Practices to Respond to Healthcare Transform...
How to Engage Physicians in Best Practices to Respond to Healthcare Transform...
PYA, P.C.
 
appendix-4--powerpoint-presentation-single-unit-transfusion.pdf
appendix-4--powerpoint-presentation-single-unit-transfusion.pdfappendix-4--powerpoint-presentation-single-unit-transfusion.pdf
appendix-4--powerpoint-presentation-single-unit-transfusion.pdf
htpplqzyafxxsptfln
 
Improving Healthcare Quality and Safety while Reducing Costs through Clinical...
Improving Healthcare Quality and Safety while Reducing Costs through Clinical...Improving Healthcare Quality and Safety while Reducing Costs through Clinical...
Improving Healthcare Quality and Safety while Reducing Costs through Clinical...
UCLA CTSI
 
Hugh Gravelle: The impact of care quality on patient choice
Hugh Gravelle: The impact of care quality on patient choiceHugh Gravelle: The impact of care quality on patient choice
Hugh Gravelle: The impact of care quality on patient choiceNuffield Trust
 
8 march 09.05 linda aiken
8 march 09.05 linda aiken8 march 09.05 linda aiken
8 march 09.05 linda aiken
NHS England
 
Implementation science tailored to precision prevention
Implementation science tailored to precision preventionImplementation science tailored to precision prevention
Implementation science tailored to precision prevention
Graham Colditz
 
Generating Quality Data through Collaborative Research with an ACO
Generating Quality Data through Collaborative Research with an ACOGenerating Quality Data through Collaborative Research with an ACO
Generating Quality Data through Collaborative Research with an ACO
Todd Berner MD
 

Similar to TH Jan 2016 v3 (20)

Current Issues Affecting Cancer Care in Puerto Rico
Current Issues Affecting Cancer Care in Puerto RicoCurrent Issues Affecting Cancer Care in Puerto Rico
Current Issues Affecting Cancer Care in Puerto Rico
 
Edifecs: Demonstrating who you are in CJR
Edifecs: Demonstrating who you are in CJREdifecs: Demonstrating who you are in CJR
Edifecs: Demonstrating who you are in CJR
 
Pharmacy's Emerging Role in Accountable Care Organizations (ACO)
Pharmacy's Emerging Role in Accountable Care Organizations (ACO)Pharmacy's Emerging Role in Accountable Care Organizations (ACO)
Pharmacy's Emerging Role in Accountable Care Organizations (ACO)
 
Debunking the myths about the hospitalists
Debunking the myths about the hospitalistsDebunking the myths about the hospitalists
Debunking the myths about the hospitalists
 
powerpoint-presentation-Multi-verse tecto.pdf
powerpoint-presentation-Multi-verse tecto.pdfpowerpoint-presentation-Multi-verse tecto.pdf
powerpoint-presentation-Multi-verse tecto.pdf
 
Transitioning to Value Based Care: Tennessee Oncology, A Case Study
Transitioning to Value Based Care: Tennessee Oncology, A Case StudyTransitioning to Value Based Care: Tennessee Oncology, A Case Study
Transitioning to Value Based Care: Tennessee Oncology, A Case Study
 
David page cord standards of care 05 03-2015
David page cord standards of  care 05 03-2015David page cord standards of  care 05 03-2015
David page cord standards of care 05 03-2015
 
Physician age and outcomes in elderly patients in hospial in the US: observat...
Physician age and outcomes in elderly patients in hospial in the US: observat...Physician age and outcomes in elderly patients in hospial in the US: observat...
Physician age and outcomes in elderly patients in hospial in the US: observat...
 
Duke Industry Statistics Symposium - Real world evidence , EHRs and Cancer S...
Duke Industry Statistics Symposium -  Real world evidence , EHRs and Cancer S...Duke Industry Statistics Symposium -  Real world evidence , EHRs and Cancer S...
Duke Industry Statistics Symposium - Real world evidence , EHRs and Cancer S...
 
Care by design magill retrospective mixed methods analysis sep 21 2011
Care by design magill retrospective mixed methods analysis sep 21 2011Care by design magill retrospective mixed methods analysis sep 21 2011
Care by design magill retrospective mixed methods analysis sep 21 2011
 
Brian Griffin
Brian GriffinBrian Griffin
Brian Griffin
 
How Hospitalists Can Lead on Quality
How Hospitalists Can Lead on QualityHow Hospitalists Can Lead on Quality
How Hospitalists Can Lead on Quality
 
Impact of Multidisciplinary Discussion on Treatment Outcome For Gynecologic C...
Impact of Multidisciplinary Discussion on Treatment Outcome For Gynecologic C...Impact of Multidisciplinary Discussion on Treatment Outcome For Gynecologic C...
Impact of Multidisciplinary Discussion on Treatment Outcome For Gynecologic C...
 
How to Engage Physicians in Best Practices to Respond to Healthcare Transform...
How to Engage Physicians in Best Practices to Respond to Healthcare Transform...How to Engage Physicians in Best Practices to Respond to Healthcare Transform...
How to Engage Physicians in Best Practices to Respond to Healthcare Transform...
 
appendix-4--powerpoint-presentation-single-unit-transfusion.pdf
appendix-4--powerpoint-presentation-single-unit-transfusion.pdfappendix-4--powerpoint-presentation-single-unit-transfusion.pdf
appendix-4--powerpoint-presentation-single-unit-transfusion.pdf
 
Improving Healthcare Quality and Safety while Reducing Costs through Clinical...
Improving Healthcare Quality and Safety while Reducing Costs through Clinical...Improving Healthcare Quality and Safety while Reducing Costs through Clinical...
Improving Healthcare Quality and Safety while Reducing Costs through Clinical...
 
Hugh Gravelle: The impact of care quality on patient choice
Hugh Gravelle: The impact of care quality on patient choiceHugh Gravelle: The impact of care quality on patient choice
Hugh Gravelle: The impact of care quality on patient choice
 
8 march 09.05 linda aiken
8 march 09.05 linda aiken8 march 09.05 linda aiken
8 march 09.05 linda aiken
 
Implementation science tailored to precision prevention
Implementation science tailored to precision preventionImplementation science tailored to precision prevention
Implementation science tailored to precision prevention
 
Generating Quality Data through Collaborative Research with an ACO
Generating Quality Data through Collaborative Research with an ACOGenerating Quality Data through Collaborative Research with an ACO
Generating Quality Data through Collaborative Research with an ACO
 

TH Jan 2016 v3

  • 1. Managing Oncology Cost and Quality John Hennessy, WellRithms
  • 2. Site of service • Physician office • Hospital outpatient department • Academic medical center • NCI-designated cancer center • Dedicated integrated specialty cancer facility
  • 3. Demographics • Hospital acquiring physician owned oncology practices • Decrease in freestanding practices to about half what it was ten years ago; 2015 ASCO Oncology Census reported 45% of those surveyed were in a hospital-owned practice, 60% in the Midwest • Often the same facility is suddenly a hospital outpatient department
  • 4. Cost Implications • Avalere (2012): chemotherapy average cost $19,640 in physician office, $26,300 hospital outpatient • Milliman/Genentech (2013): hospital costs 28-52% higher than physician office (adj/met breast/colon/ NSCLC) • Moran (2013): chemotherapy cost/day 25-40% higher; chemotherapy cost/episode 25-47% higher • GAO (2015) recommends payment parity between physician office and hospital outpatient setting
  • 5. Drug Delivery models • Physician office buy-and-bill • HOPD buy-and-bill (340b) • Specialty pharmacy • White bagging • Brown bagging
  • 6. Out-of-Network • Why does your network look like it does? • Network adequacy: health plan network breadth traded off against limited discounts • In network may not mean affordable; selective discounting and layered contracts (fully-funded vs. ASO) • Provider politics: Emory eliminates employee coverage at CTCA-Georgia; UPMC vs. Highmark/ Allegheny
  • 7. Why Out-of-Network? • Patients choose their oncologist based on: • PCP recommends one oncologist • PCP suggests a choice of oncologists • Patient asks friends for recommendations • Patient searches internet • Patient seeks advice/info from advocates/advocacy group
  • 8. Why Out-of-Network? • Consumer Direct Advertising • “We’ll work with your insurance…” • Speak with a board-certified oncologist at NO COST to get your questions answered and determine if you are a candidate…” • Second opinion advertising
  • 9. Other factors • Financial toxicity • Logistical toxicity • SPD/benefit design • Clinical trials